近期，《NeuroMarkers》 (《神经标志物（英文）》)杂志上发表的5篇文章为我们带来了全新的视角和研究成果。这些研究涵盖生物标志物的发现、验证及其潜在的临床价值，让我们看到了阿尔茨海默病诊疗新的曙光。

A new fluid biomarker for Parkinson’s disease (PD) was developed, offering a high-accuracy biological classification, ...

ACI-35.030, partnered with Johnson & Johnson, is designed to stimulate the body to generate antibodies against tau protein, one of the factors though to play a role in the development of AD dementia.